Ascend Wellness Holdings (AAWH) Current Assets (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Current Assets came in at $189.0 million in Q1 2026, down 20.39% year-on-year from $237.4 million in Q1 2025, and down 9.56% quarter-over-quarter from $208.9 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Current Assets (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Current Assets history runs 7 years deep, the most recent figure standing at $189.0 million for Q1 2026.
- On a quarterly basis, Current Assets fell 20.39% year-over-year to $189.0 million in Q1 2026; TTM through Mar 2026 was $189.0 million, a 20.39% decrease from a year earlier, with the FY2025 full-year figure at $208.9 million, down 8.91% from the prior year.
- Current Assets slipped to $189.0 million in Q1 2026 per AAWH's latest filing, from $208.9 million in the prior quarter.
- Across five years, Current Assets topped out at $260.6 million in Q1 2022 and bottomed at $189.0 million in Q1 2026.
- The 5-year median for Current Assets is $219.1 million (2022), against an average of $222.2 million.
- Biggest YoY gain for Current Assets was 84.7% in 2022; the steepest drop was 26.89% in 2022.
- Year by year, Current Assets stood at $198.7 million in 2022, then climbed by 15.15% to $228.9 million in 2023, then grew by 0.23% to $229.4 million in 2024, then decreased by 8.91% to $208.9 million in 2025, then decreased by 9.56% to $189.0 million in 2026.
- Per Business Quant, the three latest AAWH Current Assets figures stand at $189.0 million (Q1 2026), $208.9 million (Q4 2025), and $209.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 188.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188.96 Mn |
| Dec 31, 2025 | 208.95 Mn |
| Sep 30, 2025 | 209.21 Mn |
| Jun 30, 2025 | 225.65 Mn |
| Mar 31, 2025 | 237.38 Mn |
| Dec 31, 2024 | 229.38 Mn |
| Sep 30, 2024 | 213.58 Mn |
| Jun 30, 2024 | 236.26 Mn |
| Mar 31, 2024 | 232.04 Mn |
| Dec 31, 2023 | 228.86 Mn |
| Sep 30, 2023 | 211.33 Mn |
| Jun 30, 2023 | 213.14 Mn |
| Mar 31, 2023 | 204.21 Mn |
| Dec 31, 2022 | 198.74 Mn |
| Sep 30, 2022 | 219.09 Mn |
| Jun 30, 2022 | 259.95 Mn |
| Mar 31, 2022 | 260.55 Mn |
| Dec 31, 2021 | 258.01 Mn |
| Sep 30, 2021 | 299.67 Mn |
| Jun 30, 2021 | 189.40 Mn |